TeraPore Technologies, Inc.
Biotechnology company · South San Francisco, California, United States
TeraPore Technologies, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2013. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $224,929 in total, most recently in 2015. It has reported private securities offerings to the US SEC, most recently $1.8 million sold in a notice filed in 2018.
TeraPore Technologies at a glance
What does TeraPore Technologies do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $224,929 in total (2015).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $1.8 million sold (2018).
Frequently asked questions about TeraPore Technologies
Where is TeraPore Technologies headquartered?
TeraPore Technologies, Inc. is headquartered in South San Francisco, California, United States.
What does TeraPore Technologies do?
TeraPore Technologies, Inc. is a biotechnology company.
When was TeraPore Technologies founded?
The earliest incorporation on record for TeraPore Technologies, Inc. is in 2013, according to public company registers.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences